Zynex gains on higher Q2 orders
** Shares of medical device maker Zynex Inc ZYXI.O up 3.2%
at $9.4
** Reports 51% increase in Q2 orders over same period in
2022
** Confirms previous estimates for Q2 rev between $43.5 mln
and $45.5 mln and EPS between $0.03-$0.07
** Reiterates FY2023 rev outlook between $180 mln and $200
mln and EPS outlook between $0.40-$0.50
** ZYXI down 33% YTD
(Reporting by Anandita Mehrotra in Bengaluru)
((Anandita.Mehrotra@thomsonreuters.com))
Recent news on Zynex
See all newsBrief: Court Confirms Zynex Plan Of Reorganization On March 19, 2026 - SEC Filing
Brief: Zynex Inc Says SEC Concluded Investigation Into Zynex, No Enforcement Action Planned
Brief: Zynex Inc Resolves Federal Investigation Into Business Practices
Brief: Zynex Secures $22.3 Million Dip Facility From Lenders And CEO
Brief: Zynex Financial Restructuring Puts Company On Path To Long-Term Success